- Home
- Applications
- austria
- medical care
Show results for
Refine by
Medical Care Product Applications In Austria
10 applications found
Premium
Impurities in air (chromaCO) or O2 or N2O. Formaldehyde or ETO or ...
ByChromatotec based in Saint-André de Cubzac, FRANCE
In the face of the coronavirus pandemic, it is time for the nanotechnology community to shine and build on its experience with nanoscale materials and drug delivery to provide knowledge and tools for COVID-19 [prevention, diagnostics,] vaccine and therapeutics development (Nature Nanotechnology volume 15, page 617(2020)) ...
ByPhornano Holding GmbH based in Korneuburg, AUSTRIA
Glaucoma is a group of diseases that damage the eye’s optic nerve and can, if left untreated, cause vision impairment and even blindness. Glaucoma is asymptomatic (meaning it occurs without noticeable symptoms appearing). It can often go undiagnosed without proper check-ups and can get worse over time. Although the development of glaucoma is not completely understood, we do know that it damages the nerve fibers in the optic nerve and in the retina, limiting a person’s field of view and quality of ...
ByGlaukos Corporation based in San Clemente, CALIFORNIA (USA)
An antibody deficiency is always a manifestation of the disturbed maturation or function of lymphocytes in the blood. The cells only react inadequately, if at all, to invading pathogens, and the immune system is incapable of maintaining a normal concentration of antibodies in the ...
ByBiotest AG based in Dreieich, GERMANY
Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular ...
ByGlaukos Corporation based in San Clemente, CALIFORNIA (USA)
The treatment differs according to the severity of the haemophilia, which is classified as mild, moderate or severe, depending on how much clotting factor is still detectable in the patient’s blood. Most patients have severe haemophilia A (residual activity of factor VIII less than ...
ByBiotest AG based in Dreieich, GERMANY
The development of laser technology extends back to the time around 1920 to Albert Einstein. After the first laser was constructed in 1960 the advances in laser technology developed in leaps and ...
ByHeltschl Medizintechnik GmbH based in Schlüsslberg, AUSTRIA
The laser light is conducted through a special disposable light conductor directly into the lower arm vein or a similarly large venous blood vessel in the arm or leg. The treatment is performed in a relaxed state in recumbent position. Only with this form of blood irradiation is an exact and safe dosage possible. The performance of the laser device is optimised such that no heat development occurs in the blood vessel. The physician decides about the exact number of the treatments, the optimum treatment interval ...
ByHeltschl Medizintechnik GmbH based in Schlüsslberg, AUSTRIA
Immunoglobulins (antibodies) are vitally important proteins which circulate in the blood and perform a wide variety of tasks. They influence markedly the balance of our immune ...
ByBiotest AG based in Dreieich, GERMANY
The low level laser therapy is successfully used in nearly all areas of medicine. Numerous studies and long-term clinical experiences substantiate the efficacy of the low level laser ...
ByHeltschl Medizintechnik GmbH based in Schlüsslberg, AUSTRIA